At a glance
- Originator Roche
- Class Anxiolytics; Neuroprotectants; Small molecules
- Mechanism of Action GABA A receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Anxiety disorders
Most Recent Events
- 14 Feb 1995 No-Development-Reported for Anxiety disorders in Switzerland (Unknown route)